The big C: China biotech start-ups get cutting edge on cancer
The evolution of cancer treatments in China is a bellwether for biotech development in the country and its capacity for genuine innovation. Most PE and VC investors aren’t shying away
“The core reason for the formation of tumors is the aging of the human body. As people live longer, the chances of getting tumors are greater. In addition, there is no method to completely cure tumors....
More on Greater China
Latest News
AVCJ daily bulletin returns May 20
AVCJ’s daily bulletin will not be published on May 19 due to a public holiday in Hong Kong.
Indonesia's Gojek, Tokopedia merge as GoTo
Gojek and Tokopedia, two of Indonesia’s best-funded technology start-ups, have completed a merger, forming what they claim is the largest mobile on-demand services and payments platform in Southeast Asia.
China distress specialist DCL targets $466m fundraise
DCL Investments, one of China’s first private equity firms to focus on distressed assets, is looking to raise RMB3 billion ($466 million) for its latest renminbi-denominated fund.
Japan microsatellite developer gets $24m Series C
Japanese microsatellite developer Axelspace has raised JPY2.6 billion ($24 million) in Series C funding from a group of domestic VCs, including Sparx Group.